References
Collins LK et al (2017) Cutaneous adverse effects of the immune checkpoint inhibitors. Curr Probl Cancer 41(2):125–128. https://doi.org/10.1016/j.currproblcancer.2016.12.001
Cook JL, Perone JB (2003) A prospective evaluation of the incidence of complications associated with Mohs micrographic surgery. Arch Dermatol 139(2):143–152. https://doi.org/10.1001/archderm.139.2.143
Martins F et al (2019) Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance. Nat Rev Clin Oncol 16(9):563–580. https://doi.org/10.1038/s41571-019-0218-0
Vaddepally RK et al (2020) Review of indications of FDA-approved immune checkpoint inhibitors per NCCN guidelines with the level of evidence. Cancers (Basel). https://doi.org/10.3390/cancers1203073
Funding
None.
Author information
Authors and Affiliations
Contributions
C.P. and H.P. wrote the first draft of the manuscript. D.S. and R.N. provided review, editing, and supervision. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This research study was conducted retrospectively. The UT Southwestern Institutional Review Board reviewed and accepted this study, which was determined to meet exempt criteria under 25 CFR 46.104(d).
Consent to participate/publish
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Puza, C.J., Pyle, H.J., Srivastava, D. et al. Immune checkpoint inhibitors and dermatologic procedures: a retrospective review of postoperative complications. Arch Dermatol Res 315, 2941–2942 (2023). https://doi.org/10.1007/s00403-023-02701-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-023-02701-7